Meanwhile, both LYVE-1 and OVA-647 area coverage in the dCLNs was also significantly increased after OT administration in AD mice (Figure 4G-I), illustrating the recovery of impaired structure and function of the dCLNs. Here, LYVE1 is linked to Alzheimer disease.